Clinical Trial Update: Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment [Phase 2, Phase 3]

View source ↗

Summary

Phase 2 and Phase 3 clinical trials evaluating proton pump inhibitor treatment for laryngopharyngeal reflux have completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Laryngopharyngeal Reflux

Snippet

Sponsor: University of Utah | Conditions: Laryngopharyngeal Reflux | Phase 2, Phase 3 | Status: COMPLETED